Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2020 | Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study | CLINICAL LUNG CANCER |